Concurrent Investment Advisors LLC Raises Holdings in McKesson Corporation $MCK

Key Points

• Concurrent Investment Advisors increased its stake in McKesson by 62.9% in Q4 to 3,158 shares, valued at approximately $2.59 million.
• Company insiders have sold a total of 3,592 shares worth about $3.52 million in the past 90 days, and insiders now own just 0.08% of the stock.
• McKesson beat Q results with $9.34 EPS vs. $9.19 expected and $106.16 billion revenue, set FY2026 guidance of 38.80–39.20 EPS, and carries a consensus analyst rating of Moderate Buy with an average target of about $972.27.

Concurrent Investment Advisors LLC grew its position in McKesson Corporation (NYSE:MCK - Free Report) by 62.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,158 shares of the company's stock after buying an additional 1,219 shares during the quarter. Concurrent Investment Advisors LLC's holdings in McKesson were worth $2,590,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in MCK. Generali Investments Management Co LLC increased its position in McKesson by 500.0% during the 4th quarter. Generali Investments Management Co LLC now owns 1,014 shares of the company's stock valued at $832,000 after buying an additional 845 shares in the last quarter. Calamos Wealth Management LLC increased its position in McKesson by 3.1% during the 4th quarter. Calamos Wealth Management LLC now owns 5,551 shares of the company's stock valued at $4,553,000 after buying an additional 167 shares in the last quarter. ProVise Management Group LLC increased its position in McKesson by 3.0% during the 4th quarter. ProVise Management Group LLC now owns 14,991 shares of the company's stock valued at $12,297,000 after buying an additional 433 shares in the last quarter. China Universal Asset Management Co. Ltd. increased its position in McKesson by 3.4% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 1,600 shares of the company's stock valued at $1,314,000 after buying an additional 52 shares in the last quarter. Finally, Lebenthal Global Advisors LLC increased its position in McKesson by 99.2% during the 4th quarter. Lebenthal Global Advisors LLC now owns 741 shares of the company's stock valued at $608,000 after buying an additional 369 shares in the last quarter. 85.07% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at McKesson

In related news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $955.00, for a total value of $313,240.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Leann B. Smith sold 190 shares of the stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total value of $179,550.00. Following the completion of the sale, the executive vice president directly owned 2,989 shares of the company's stock, valued at approximately $2,824,605. This represents a 5.98% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 3,592 shares of company stock worth $3,518,555. 0.08% of the stock is owned by insiders.

McKesson Trading Up 0.8%

Shares of MCK stock opened at $834.55 on Wednesday. The company has a market capitalization of $102.22 billion, a P/E ratio of 24.00, a P/E/G ratio of 1.20 and a beta of 0.42. The business's 50 day moving average is $899.76 and its two-hundred day moving average is $859.72. McKesson Corporation has a 12-month low of $637.00 and a 12-month high of $999.00.

McKesson (NYSE:MCK - Get Free Report) last released its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, beating the consensus estimate of $9.19 by $0.15. The business had revenue of $106.16 billion for the quarter, compared to the consensus estimate of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The business's quarterly revenue was up 11.4% compared to the same quarter last year. During the same quarter last year, the business posted $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, research analysts predict that McKesson Corporation will post 39.02 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 1st. Stockholders of record on Monday, June 1st will be given a $0.82 dividend. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. The ex-dividend date is Monday, June 1st. McKesson's dividend payout ratio (DPR) is 9.43%.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the company. TD Cowen upped their target price on McKesson from $1,000.00 to $1,012.00 and gave the company a "buy" rating in a research report on Thursday, February 5th. Morgan Stanley reiterated an "overweight" rating and issued a $966.00 target price on shares of McKesson in a research report on Thursday, January 29th. Mizuho upped their target price on McKesson from $880.00 to $885.00 and gave the company a "neutral" rating in a research report on Thursday, February 5th. Leerink Partners reiterated an "outperform" rating and issued a $1,085.00 target price on shares of McKesson in a research report on Thursday, March 5th. Finally, Bank of America dropped their target price on McKesson from $1,040.00 to $1,000.00 and set a "buy" rating on the stock in a research report on Monday, April 6th. Fourteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $972.27.

McKesson Profile

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.